Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metformin is widely prescribed to pregnant women with polycystic ovary syndrome (PCOS) in an attempt to reduce pregnancy complications. Metformin is not approved for this indication, and evidence for this practice is lacking. OBJECTIVES: Our objective was to test the hypothesis that metformin, from first trimester to delivery, reduces pregnancy complications in women with PCOS. DESIGN AND SETTING: We conducted a randomized, placebo-controlled, double-blind, multicenter study at 11 secondary care centers. PARTICIPANTS: The participants were 257 women with PCOS, in the first trimester of pregnancy, aged 18-42 yr. INTERVENTION: We randomly assigned 274 singleton pregnancies (in 257 women) to receive metformin or placebo, from first trimester to delivery. MAIN OUTCOME MEASURES: The prevalence of preeclampsia, gestational diabetes mellitus, preterm delivery, and a composite of these three outcomes is reported. RESULTS: Preeclampsia prevalence was 7.4% in the metformin group and 3.7% in the placebo group (3.7%; 95% CI, -1.7-9.2) (P=0.18). Preterm delivery prevalence was 3.7% in the metformin group and 8.2% in the placebo group (-4.4%; 95%, CI, -10.1-1.2) (P=0.12). Gestational diabetes mellitus prevalence was 17.6% in the metformin group and 16.9% in the placebo group (0.8%; 95% CI, -8.6-10.2) (P=0.87). The composite primary endpoint prevalence was 25.9 and 24.4%, respectively (1.5%; 95% CI, -8.9-11.3) (P=0.78). Women in the metformin group gained less weight during pregnancy compared with those in the placebo group. There was no difference in fetal birth weight between the groups. CONCLUSIONS: Metformin treatment from first trimester to delivery did not reduce pregnancy complications in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in individuals with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (91),”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [91]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Cited by
Items 301–316 of 316
Hugo Maldonado, E., Gloria López, S., Jorge Hasbún, H., Hugo Salinas, P., Parra-Cordero, M., & Enrique Valdés, R. (2016) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2016.71125
“Adicionalmente, la obesidad en forma independiente del estatus de la diabetes, contribuye al desarrollo de macrosomía y puede contrarrestar los beneficios de un buen control glicémico en estas mujeres(14).”
BackgroundTemas selectos de ginecología y obstetricia
particular, D., Paneque, A. A. E., Fernández, R. E. A., de Machala, U. T., Quiñones, M. J., particular, D., Betancourt, P. L. N., particular, D., Posada, M. E. A., & particular, D. (2022) · doi:10.48190/9789942241627
Infertility care of the PCOS patient
Knutson, A. J., & Legro, R. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85687-4.00013-0
Metformin in pregnancy: everything you always wanted to know but were afraid to ask
Biamonte, E. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.3.4
Hormonelle Regulation des menstruellen Zyklus und ihre Störungen
Ludwig, M. Z., & Weiss, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_3 · Cited by 1
Association Between Obesity in Women, Polycystic Ovary Syndrome and Adverse Obstetric Outcome
Ginod, P., & Dahan, M. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_6
Managing Insulin Resistance in Polycystic Ovary Syndrome Patients: A Literature Review
Ahmed, N. S. I., Imran, S., Omran, H., & Alsayed, N. (2024) · Contributions to management science · doi:10.1007/978-3-031-67531-7_51
Treatment of type 2 diabetes in pregnancy: Do we need to use metformin?
Fu, J. M., & Feig, D. S. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102027 · Cited by 1
Prikhod'ko, I. E. (2013) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Lin, S.-F., Chang, S., Kuo, C.-F., Lin, W.-T., Chiou, M.-J., & Huang, Y.-T. (2020) · Figshare · doi:10.6084/m9.figshare.12922819
Clinical Consequences of Abnormal Glucose Metabolism
Jensen, D. M., Ovesen, P., & Catalano, P. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-25023-1_3
Pharmacologic Treatment of Diabetes in Pregnancy
Feghali, M. N. (2026) · Clinics in Perinatology · doi:10.1016/j.clp.2026.04.006
Metformin use during pregnancy: Current evidence and clinical considerations
Kazakova, T., Zamtikova, M., Zaykov, H., Ivanova, M., & Тодорова, А. (2026) · Scripta Scientifica Medica · doi:10.14748/r6s8n597
Trouva, A., Vanky, E., Alvarsson, M., Calissendorff, J., Åsvold, B. O., Ujvári, D., & Hirschberg, A. L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1884684
Self-citationManaging Diabetes in Pregnancy
Tan, E. J. H., & SCOTT, E. M. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_21
Metadata
- Authors
- Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M.
- Affiliations
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
- Department of Public Health (P.R.) Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway;
- Sentral Hospital of Northern Norway (K.S.), 8092 Bodø, Norway;
- Elvebredden Gynekologpraksis (O.K.), 4630 Kristiansand, Norway;
- Ålesund Hospital (NO)
- Stavanger University Hospital (P.v.B.), 4011 Stavanger, Norway;
- Haugesund Hospital (T.E.), 5504 Haugesund, Norway;
- UiT The Arctic University of Norway (NO)
- Drammen Hospital (NO)
- Ringerike Hospital (G.B.), 5311 Hønefoss, Norway;
- University of Bergen (NO)
- Lillehammer Hospital (C.B., A.H.B., A.D.), 2629 Lillehammer, Norway
- Buskerud Hospital (K.F.B., I.A.), 3004 Drammen, Norway;
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-12-01
- Volume
- 95
- Issue
- 12
- Pages
- E448-E455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1986803895
- Cited by
- 315
- References
- 28
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 16 · 2016: 21 · 2015: 17 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Helse Midt-Norge
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metformin, polycystic ovary syndrome, pregnancy complications, preeclampsia, gestational diabetes mellitus, preterm birth, gestational weight gain, birth weight, first trimester
- MeSH terms
- Adult, Blood Pressure, Double-Blind Method, Female, Heart Rate, Humans, Metformin, Patient Compliance, Placebos, Polycystic Ovary Syndrome, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Random Allocation, Diabetes, Gestational, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.